A
Anastasiya V. Snezhkina
Researcher at Engelhardt Institute of Molecular Biology
Publications - 69
Citations - 1969
Anastasiya V. Snezhkina is an academic researcher from Engelhardt Institute of Molecular Biology. The author has contributed to research in topics: Linum & Medicine. The author has an hindex of 19, co-authored 56 publications receiving 1199 citations.
Papers
More filters
Journal ArticleDOI
ROS Generation and Antioxidant Defense Systems in Normal and Malignant Cells
Anastasiya V. Snezhkina,Anna V. Kudryavtseva,Olga L. Kardymon,Maria V Savvateeva,Nataliya V. Melnikova,George S. Krasnov,Alexey A. Dmitriev +6 more
TL;DR: This review covers the current data on the mechanisms of ROS generation and existing antioxidant systems balancing the redox state in mammalian cells that can also be related to tumors.
Journal ArticleDOI
Mitochondrial dysfunction and oxidative stress in aging and cancer
Anna V. Kudryavtseva,George S. Krasnov,Alexey A. Dmitriev,Boris Alekseev,Olga L. Kardymon,Asiya F. Sadritdinova,Maria S. Fedorova,Anatoly V. Pokrovsky,Nataliya V. Melnikova,Andrey Kaprin,Alexey Moskalev,Alexey Moskalev,Anastasiya V. Snezhkina +12 more
TL;DR: This review focuses on the similarities between ageing-associated and cancer-associated oxidative stress and mitochondrial dysfunction as their common phenotype and suggests that the oxidative stress as a cause and/or consequence of the mitochondrial dysfunction is one of the main drivers of these processes.
Journal ArticleDOI
Important molecular genetic markers of colorectal cancer
Anna V. Kudryavtseva,Anastasia V. Lipatova,Andrew R. Zaretsky,Alexey Moskalev,Maria S. Fedorova,Anastasiya S. Rasskazova,Galina A. Shibukhova,Anastasiya V. Snezhkina,Andrey Kaprin,Boris Alekseev,Alexey A. Dmitriev,George S. Krasnov +11 more
TL;DR: The present review discusses the most important and well-studied CRC biomarkers, and their potential clinical significance and current approaches to molecular classification of colorectal tumors.
Journal ArticleDOI
Deregulation of glycolysis in cancer: glyceraldehyde-3-phosphate dehydrogenase as a therapeutic target
TL;DR: The role of GAPDH in carcinogenesis and the possibility of using this target for anticancer therapy is focused on and limitations of this approach may come from the versatility of the GAPDh enzyme, since it combines glycolytic, pro-apoptotic and other activities.
Journal ArticleDOI
The Dysregulation of Polyamine Metabolism in Colorectal Cancer Is Associated with Overexpression of c-Myc and C/EBPβ rather than Enterotoxigenic Bacteroides fragilis Infection
Anastasiya V. Snezhkina,George S. Krasnov,Anastasiya V. Lipatova,Asiya F. Sadritdinova,Olga L. Kardymon,Maria S. Fedorova,Nataliya V. Melnikova,O. A. Stepanov,Andrew R. Zaretsky,Andrey Kaprin,Boris Alekseev,Alexey A. Dmitriev,Anna V. Kudryavtseva +12 more
TL;DR: Two mediators of metabolic reprogramming, inflammation, and cell proliferation c-Myc and C/EBPβ may serve as regulators of polyamine metabolism genes (SMOX, AZIN1, MTAP, SRM, ODC1, AMD1, and AGMAT) as they are overexpressed in tumors, have binding site according to ENCODE ChIP-Seq data, and demonstrate strong coexpression with their targets.